文献速递慢性肾脏病肾小球疾病

儿童CKD中血脂异常随GFR下降和蛋白尿增加的变化

Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-11-11

本研究在CKD儿童队列中前瞻性随访508名患儿,采用线性混合效应模型分析血脂指标与GFR、蛋白尿及BMI的纵向关系。结果显示血脂异常在儿童CKD中常见且持续,并随GFR下降、蛋白尿加重和BMI增加而恶化,肾小球性CKD的关联更强。

要点

  • 儿童CKD患者血脂异常常见且持续,随年龄增长而加重。
  • 蛋白尿增加与non-HDL胆固醇和甘油三酯升高独立相关。
  • GFR下降与non-HDL胆固醇升高(肾小球性)和HDL胆固醇降低(非肾小球性)相关。

核心结论

  • 血脂异常是儿童CKD常见且持续的并发症,随GFR下降、蛋白尿加重和BMI增加而恶化。

研究设计与样本

  • CKD in Children研究前瞻性随访508名儿童,其中非肾小球性CKD占76%,肾小球性CKD占24%,每人有2-6次血脂测量,中位随访4年(IQR 2.1-6.0)。
  • 采用多变量线性混合效应模型量化血脂指标与GFR、蛋白尿和BMI的纵向关系。

主要发现

  • 非肾小球性CKD患儿基线血脂异常患病率为35%,随年龄增长显著增加;肾小球性CKD患儿基线为43%,且持续存在。
  • 蛋白尿纵向增加与non-HDL胆固醇升高独立相关(非肾小球性:4.9 mg/dl,IQR 3.4-6.4;肾小球性:8.5 mg/dl,IQR 6.0-11.1),与甘油三酯升高也相关(非肾小球性:3%,IQR 0.8%-6%;肾小球性:5%,IQR 0.6%-9%)。
  • 随访中GFR下降与非肾小球性CKD患儿HDL胆固醇降低(-1.2 mg/dl,IQR -2.1至-0.4)及肾小球性CKD患儿non-HDL胆固醇升高(3.9 mg/dl,IQR 1.4-6.5)显著相关。
  • BMI增加也影响多种血脂变化;肾小球性CKD中non-HDL胆固醇(9 mg/dl vs 1.2 mg/dl;P<0.001)和甘油三酯(14% vs 3%;P=0.004)与BMI变化的关联更强。

临床怎么用

  • 对儿童CKD患者应定期监测血脂,尤其关注蛋白尿加重、GFR下降和BMI增加者。
  • 肾小球性CKD患儿血脂异常与BMI等变化的关联更强,可能需更积极管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Dyslipidemia, a risk factor for cardiovascular disease, is common in CKD but its change over time and how that change is influenced by concurrent progression of CKD have not been previously described. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In the CKD in Children study we prospectively followed children with progressive CKD and utilized multivariable, linear mixed-effects models to quantify the longitudinal relationship between within-subject changes in lipid measures (HDL cholesterol, non-HDL cholesterol, triglycerides) and within-subject changes in GFR, proteinuria, and body mass index (BMI). RESULTS: A total of 508 children (76% nonglomerular CKD, 24% glomerular CKD) had 2-6 lipid measurements each, with a median follow-up time of 4 (interquartile range [IQR], 2.1-6.0) years. Among children with nonglomerular CKD, dyslipidemia was common at baseline (35%) and increased significantly as children aged; 43% of children with glomerular CKD had dyslipidemia at baseline and demonstrated persistent levels as they aged. Longitudinal increases in proteinuria were independently associated with significant concomitant increases in non-HDL cholesterol (nonglomerular: 4.9 [IQR, 3.4-6.4] mg/dl; glomerular: 8.5 [IQR, 6.0-11.1] mg/dl) and triglycerides (nonglomerular: 3% [IQR, 0.8%-6%]; glomerular: 5% [IQR, 0.6%-9%]). Decreases in GFR over follow-up were significantly associated with concomitant decreases of HDL cholesterol in children with nonglomerular CKD (-1.2 mg/dl; IQR, -2.1 to -0.4 mg/dl) and increases of non-HDL cholesterol in children with glomerular CKD (3.9 mg/dl; IQR, 1.4-6.5 mg/dl). The effects of increased BMI also affected multiple lipid changes over time. Collectively, glomerular CKD displayed stronger, deleterious associations between within-subject change in non-HDL cholesterol (9 mg/dl versus 1.2 mg/dl; P<0.001) and triglycerides (14% versus 3%; P=0.004), and within-subject change in BMI; similar but quantitatively smaller differences between the two types of CKD were noted for associations of within-subject change in lipids to within-subject change in GFR and proteinuria. CONCLUSIONS: Dyslipidemia is a common and persistent complication in children with CKD and it worsens in proportion to declining GFR, worsening proteinuria, and increasing BMI.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Saland JM, Kupferman JC, Pierce CB, et al. Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD. Clin J Am Soc Nephrol. 2019. PMID: 31712386. doi:10.2215/CJN.03110319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。